TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 120 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,388,000 | -15.6% | 126,266 | -0.8% | 0.29% | -10.8% |
| Q2 2021 | $9,935,000 | -43.4% | 127,345 | -31.4% | 0.32% | -44.3% |
| Q1 2021 | $17,562,000 | -57.1% | 185,665 | -44.8% | 0.58% | -59.1% |
| Q4 2020 | $40,963,000 | +66.0% | 336,173 | +19.0% | 1.42% | +30.3% |
| Q3 2020 | $24,674,000 | +95.4% | 282,440 | +44.5% | 1.09% | +83.6% |
| Q2 2020 | $12,628,000 | +488.2% | 195,503 | +306.6% | 0.60% | +341.5% |
| Q1 2020 | $2,147,000 | – | 48,083 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |